Human papillomavirus: Clinical significance and malignant potential

International Journal of Dermatology

Volumn 40, Issue 6, 2001, Pages 373-379

  Nebesio, Christy L ^a,b   Mirowski, Ginat W ^a,b   Chuang, Tsu Yi ^a,b,c  

^a INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CIDOFOVIR; DICHLOROACETIC ACID; FLUOROURACIL; IMIQUIMOD; INTERFERON; ISOTRETINOIN; PODOPHYLLIN; PODOPHYLOTOXIN; RECOMBINANT VACCINE; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VACCINE;

BOWENOID PAPULOSIS; CANCER; CARBON DIOXIDE LASER; CLINICAL TRIAL; CONDYLOMA; CONFERENCE PAPER; CRYOSURGERY; CURETTAGE; DRUG SCREENING; ELECTROSURGERY; EXCISION REPAIR; GENITAL TRACT CANCER; GENITAL TRACT INFECTION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; POPULATION RISK; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS; VERRUCOUS CARCINOMA; WART VIRUS;

CONDYLOMATA ACUMINATA; FEMALE; HUMANS; INCIDENCE; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PRIMARY PREVENTION; PROGNOSIS; RISK ASSESSMENT; TUMOR VIRUS INFECTIONS;

EID: 0034822709     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2001.01232.x     Document Type: Conference Paper

References (57)

1. Nucleotide sequence and characterization of human papillomavirus type 83, a novel genital papillomavirus
2. Papillomavirus and HPV typing
3. Human papillomavirus infection with particular reference to genital disease
4. Medical progress: Carcinoma of the anal canal
5. External genital warts: Report of the American Medical Association Consensus Conference. AMA expert panel on external genital warts
6. Condyloma acuminatum in Rochester, Minnesota, 1950-1978. I. Epidemiology and clinical features
7. Condyloma acuminatum - United States, 1966-1981
8. Epidemiology of genital human papillomavirus
9. An overview of sexually transmitted diseases. Part II
10. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer
11. History of genital warts in 10,838 women 20 to 29 years of age from the general population: Risk factors and association with Papanicolaou smear history
12. Epidemiology of genital human papillomavirus infection
13. Advances in the diagnosis and treatment of human papillomavirus infections
14. An aggressive and invasive growth of juvenile papillomas involving the total respiratory tract
15. Condyloma acuminatum in Rochester, Minnesota, 1950-1978. II. Anaplasias and unfavorable outcomes
16. Low risk of perinatal transmission of human papillomavirus: Results from a prospective cohort study
17. Clinical, histopathologic, and molecular aspects of cutaneous human papillomavirus infections
18. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica
19. Cervical cytology after 2000 where to go?
20. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer
21. Human papilloma virus in melanoma biopsy specimens and its relation to melanoma progression
22. Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival
23. Prognostic implication of human papillomavirus infection in squamous cell carcinoma of the lung
24. An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China
25. Papillomavirus in esophageal papillomas and carcinomas
26. Alcohol, smoking, and papillomavirus infection as risk factors for esophageal squamous cell papilloma and esophageal squamous cell carcinoma in Italy
27. Human papillomavirus involvement in esophageal carcinogenesis in the high-incidence area of China
28. The epidemiology of lip cancer: A review of global incidence and aetiology
29. Transitional cell and uncommon urothelial carcinoma of renal pelvis/ureter and bladder: Low incidence of human papilloma virus
30. Human papillomavirus antibody and risk of prostate cancer
31. Condylomata acuminata and risk of cancer: An epidemiological study
32. Cervical intraepithelial neoplasia, anogenital cancer, and other cancer types in women after hospitalization for condylomata acuminata
33. Condyloma acuminata (genital warts): An epidemiologic view
34. The role of human papillomaviruses in anogenital cancers
35. Epidemiology of human papilloma virus infections and genital neoplasia
36. The natural history of human papillomavirus (HPV) atypia of the cervix
37. Genital warts and their treatment
38. Immunology of human papillomavirus infection
39. Epidemiologic determinants of seroreactivity of human papillomavirus type 16 virus-like particles in cervical HPV 16 DNA-positive and -negative women
40. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women
41. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts
42. Self-administered topical 5% imiquimod cream for external anogenital warts
43. Treatment of genital warts with an immune-response modifier (imiquimod)
44. A randomized, controlled, safety, study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients: Imiquimod study group
45. Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts
46. A phase I/II study of cidofovir topical gel for refractory condyloma acuminatum in patients with HIV infection
47. Treatment of condylomata acuminata with oral isotretinoin
48. Development of intralesional therapy with fluorouracil/adrenaline injectable gel for management of condylomata acuminata: Two phase II clinical studies
49. Human papillomavirus vaccines
50. The role of vaccines in the control of STDs: HPV vaccines
51. Papillomavirus-like particles and HPV vaccine development
52. Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV 16 vaccination
53. Toward a human papillomavirus vaccine
54. Detection of human papillomavirus DNA in PUVA-associated non-melanoma skin cancers
55. A putative human papillomavirus type 57 new subtype isolated from plantar epidermoid cysts without intracytoplasmic inclusion bodies
56. The genomes of four novel HPV types defined by differences of their L1 genes, show high conservation of the E7 gene and the URR
57. The role of human papillomavirus in anogenital cancer